On March 2 and 4, Axinn partner Ted Mathias spoke at the 2020 Festival of Biologics: USA in San Diego. This three-day event provided a meeting place for the life science community to bridge the gap between academia and industry.

Ted spoke on a panel entitled, "Three Topics Covering the BPCIA’s Past, Present & Future." This panel discussed why Amgen’s Trastuzumab and Bevacizumab launches mattered.